沙利度胺联合三苯氧胺治疗Ⅳb期牙龈恶性黑色素瘤一例

DOI: 10.7507/1002-0179.20150518, PP. 1808-1809

Keywords: 恶性黑色素瘤,沙利度胺,三苯氧胺

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	1 Tas F, Camlica H, Topuz E. Temozolomide in combination with fotemustine in patients with metastatic melanoma[J]. Cancer Chemother Pharmacol, 2008, 62(2): 293-298.
[2]	2 Trinh VA. Current management of metastatic melanoma[J]. Am J Health Syst Pharm, 2008, 65(24 Suppl 9): S3-S8.
[3]	3 蒋骑, 黄俊辉. 沙利度胺联合DVP化疗方案治疗恶性黑色素瘤28例[J]. 现代肿瘤医学, 2009, 17(1): 110-111.
[4]	4 张云, 殷忠美, 王守峰, 等. 上牙龈多发恶性黑色素瘤一例报道[J]. 中国肿瘤外科杂志, 2012, 4(5): 309-310.
[5]	5 Chmielowski B. Ipilimumab: a First-in-Class T-Cell potentiator for metastatic melanoma[J]. J Skin Cancer, 2013(2013): 423829.
[6]	6 李丹丹, 刘磊. Ipilimumab在恶性黑色素瘤免疫治疗中的进展[J]. 华西医学, 2012, 27(4): 135-139.
[7]	7 Wolchok JD, Kluger H, Callahan MK, et al. Nivolumab plus ipilimumab in advanced melanoma[J]. N Engl J Med, 2013, 369(2): 122-133.
[8]	8 练炼, 马德亮, 陶敏. 恶性黑色素瘤的分子靶向治疗进展[J]. 实用肿瘤杂志, 2010, 25(2): 109-112.
[9]	9 Hwu WJ, Krown SE, Panageas KS, et al. Temozolomide plus Thalidomide in patients with advanced melanoma: results of a dose-finding trial[J]. J Clin Oncol, 2002, 20(11): 2610-2615.
[10]	10 于燕霞, 石远凯. 沙利度胺在恶性肿瘤治疗中的应用[J]. 癌症进展, 2005, 3(4): 353-359.

Full-Text